tizanidine has been researched along with cyclobenzaprine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Burger, J; Coelho, C; Elgoyhen, AB; Figueiredo, R; Frank, E; Landgrebe, M; Langguth, B; Schecklmann, M | 1 |
Alencar, FG; Becker, A; Viana, PG; Zamperini, C | 1 |
1 review(s) available for tizanidine and cyclobenzaprine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for tizanidine and cyclobenzaprine
Article | Year |
---|---|
Reduction of tinnitus severity by the centrally acting muscle relaxant cyclobenzaprine: an open-label pilot study.
Topics: Adult; Aged; Amitriptyline; Clonidine; Female; Humans; Male; Middle Aged; Muscle Relaxants, Central; Orphenadrine; Pilot Projects; Propiophenones; Severity of Illness Index; Tinnitus; Treatment Outcome | 2012 |
Patient education and self-care for the management of jaw pain upon awakening: a randomized controlled clinical trial comparing the effectiveness of adding pharmacologic treatment with cyclobenzaprine or tizanidine.
Topics: Adolescent; Adult; Aged; Amitriptyline; Analgesics, Non-Narcotic; Clonidine; Double-Blind Method; Facial Pain; Female; Humans; Ibuprofen; Male; Middle Aged; Muscle Relaxants, Central; Pain Measurement; Patient Education as Topic; Placebos; Self Care; Severity of Illness Index; Sleep; Temporomandibular Joint Dysfunction Syndrome; Treatment Outcome; Young Adult | 2014 |
1 other study(ies) available for tizanidine and cyclobenzaprine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |